Recently, the action of Semaglutide has been updated frequently.
Nutrition Review published an article this year titled “What is the new ingredient (① |)? Semaglutide is mainly used to reduce blood sugar, but because the ingredient has a certain effect of suppressing appetite, it is suitable for weight loss among people.
According to the reporter, there are three dosage forms of Semaglutide at present, which are injections, tablets and gummy dosage forms.
Among them, injections and tablets have already entered the Chinese market.
Injections and tablets have already entered our country
In November 2024, Novo Nordisk announced the listing of Simeaglutide injection Novoying in China, which opened the Chinese market of Simeaglutide.
On January 11, 2025, Novo Nordisk announced that the world’s first oral glucagon-like peptide-1 receptor agonist (GLP-1RA), Novo Xin (Semaglutide tablet), is fully available in China.
For example, Simaglutide injection, which has entered the Chinese market for 2 months, is the current market performance?
Its understood that the current offline sales mainly in medical channels, such as pharmacies and clinics. Online main instant retail.
The reporter searched the keyword “Simeiglutide” on the Meituan platform and saw that the highest price of Simeiglutide injection was 710 yuan, and the monthly sales data reached 5000+.
It can also seen that currently, semaglutide injection still prescribed.
The delivery time is different, most in the form of express delivery, receiving time is usually 2 to 3 days, and instant distribution only two pharmacies.
It can seen that Simeaglutide injection is still in the stage of mass sale.
Reviews reached 999+, and the reviews mixed, but most of the skeptical consumers limited to the packaging of the Smaglutide injection and concerned about whether the drug could continue to used after the temperature dropped.
But in terms of weight loss effect, its firmly believed and highly praised.
Among them, 20 people commented that “injections do not hurt”, and 39 people commented that the price of the sale is lower than that of offline pharmacies.
With its own heat, Simiglutide, now in addition to domestic imported brands, there are also pharmaceutical companies with this wave of heat to start the layout of Simiglutide this business line.
According to the reporter’s understanding, at present, the Simaglutide injection developed by several companies, mainly Shiyao Group, Chen An Biological, Norbot, Sino-American East China Pharmaceutical, Lizon Group and Bett Biological, is still in the stage of diabetes clinical trial III.
Among them, the Semaglutide of Lizon Group and Bett Biology has also reached the stage of clinical trial III in the field of weight loss.
Gummy formulations that have not yet entered China
As for the gummy dosage form, which currently limited to circulation in the international market, on December 31, 2024, the world’s first complex Semaglutide gummy launched by digital health company Eden.
This is the third dosage form after injections and tablets, the gummy version, which is produced by Eden, a service platform.
The idea is that most people would prefer an oral drug to an injection.
According to Eden’s website, semaglutide chewable gummy candy uses its own unique Semaglutide compound formula in addition to GLP-1, MIC and B12.
GLP-1 regulates metabolism, and the MIC and B12 in the formula may help increase energy and minimize the side effects of GLP-1.
Its well known that gummy dosage forms have significant advantages in carrying compared to injectable dosage forms.
It can also said that this a breakthrough in the dosage form of drugs, no longer adhering to the original traditional pill, injection form.
According to Eden’s website, there are currently three options for buying the Semaglutide chewable gummy candies – a quarterly package for $296 / month, a six-month package for $276 / month, and a one-year package for $246 / month.
Its website also claims that consumers can feel significant changes in their bodies after taking it for three months.
How receptive are consumers to Semaglutide in gummy formulations?
Is the market effect as expected, to achieve the purpose of selling well?
